Eli Lilly Weight Loss Competition - Search News

Order byBest matchMost fresh

News

Eli Lilly, Novo Nordisk

Eli Lilly Shares Tumble After Rival Novo?Nordisk Strikes Major Weight Loss Deal

Meanwhile, Eli Lilly's Zepbound injection has gained traction, prompting both firms to race toward more convenient weight?loss pills. Investors will watch upcoming trial readouts and regulatory decisions closely.

Continue reading

The Economist · 7d

Eli Lilly looks set to steal Novo Nordisk’s weight-loss crown

EconoTimes · 3d

Eli Lilly’s Zepbound Outperforms Wegovy in Weight Loss Head-to-Head Trial

13don MSN

Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

Compounders lose legal battle with FDA over removal of Eli Lilly’s weight loss drug from a shortage list

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results